Rhonda Patrick· PhD
So, you know, you could theoretically come to my lab and I could inject you with this stuff and you could take doxycycline and turn it on for as long as you want, and that's all theoretical. But we're not crazy, we're not going to do that. We probably need another few years of clinical testing before I can say that this is going to be usable in a wider context. But if you're wondering why are we testing the eyes, we're testing glaucoma, and blindness in old mice, it's because that's already on the market for AAV, so viral use. And it's localized, so if there's any problem, it's not going to hurt the rest of the body, anyway.